FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367049649> ?p ?o ?g. }

• W4367049649 endingPage "340" @default.
• W4367049649 startingPage "331" @default.
• W4367049649 abstract "No AccessJournal of UrologyAdult Urology26 Apr 2023Intraoperative Predictors of Sacral Neuromodulation Implantation and Treatment Response: Results From the ROSETTA TrialThis article is commented on by the following:Editorial Comment Bradley C. Gill, Sonia Thomas, Lindsey Barden, J. Eric Jelovsek, Isuzu Meyer, Christopher Chermansky, Yuko M. Komesu, Shawn Menefee, Deborah Myers, Ariana Smith, Donna Mazloomdoost, and Cindy L. Amundsen Bradley C. GillBradley C. Gill *Correspondence: Department of Urology, Cleveland Clinic, Mail Stop Q10-1, 9500 Euclid Ave, Cleveland, OH 44195 telephone: 440-461-6430; E-mail Address: [email protected] https://orcid.org/0000-0002-5568-2542 Cleveland Clinic, Cleveland, Ohio More articles by this author , Sonia ThomasSonia Thomas RTI International, Research Triangle Park, North Carolina More articles by this author , Lindsey BardenLindsey Barden RTI International, Research Triangle Park, North Carolina More articles by this author , J. Eric JelovsekJ. Eric Jelovsek Duke University, Durham, North Carolina More articles by this author , Isuzu MeyerIsuzu Meyer University of Alabama at Birmingham, Birmingham, Alabama More articles by this author , Christopher ChermanskyChristopher Chermansky University of Pittsburgh, Magee-Womens Research Institute, Pittsburgh, Pennsylvania More articles by this author , Yuko M. KomesuYuko M. Komesu University of New Mexico, Albuquerque, New Mexico More articles by this author , Shawn MenefeeShawn Menefee University of California San Diego, San Diego, California More articles by this author , Deborah MyersDeborah Myers Brown University, Providence, Rhode Island More articles by this author , Ariana SmithAriana Smith University of Pennsylvania, Philadelphia, Pennsylvania More articles by this author , Donna MazloomdoostDonna Mazloomdoost Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland More articles by this author , and Cindy L. AmundsenCindy L. Amundsen Duke University, Durham, North Carolina More articles by this author for the NICHD Pelvic Floor Disorders Network View All Author Informationhttps://doi.org/10.1097/JU.0000000000003498AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail Abstract Purpose: We determined the utility of intraoperative data in predicting sacral neuromodulation outcomes in urgency urinary incontinence. Materials and Methods: Intraoperative details of sacral neuromodulation stage 1 were recorded during the prospective, randomized, multicenter ROSETTA trial, including responsive electrodes, amplitudes, and response strengths (motor and sensory Likert scales). Stage 2 implant was performed for stage 1 success on 3-day diary with 24-month follow-up. An intraoperative amplitude response score for each electrode was calculated ranging from 0 (no response) to 99.5 (maximum response, 0.5 V). Predictors for stage 1 success and improvement at 24 months were identified by stepwise logistic regression confirmed with least absolute shrinkage and selection operator and stepwise linear regression. Results: Intraoperative data from 161 women showed 139 (86%) had stage 1 success, which was not associated with number of electrodes generating an intraoperative motor and/or sensory response, average amplitude at responsive electrodes, or minimum amplitude-producing responses. However, relative to other electrodes, a best amplitude response score for bellows at electrode 3 was associated with stage 1 failure, a lower reduction in daily urgency urinary incontinence episodes during stage 1, and most strongly predicted stage 1 outcome in logistic modeling. At 24 months, those who had electrode 3 intraoperative sensory response had lower mean reduction in daily urgency urinary incontinence episodes than those who had no response. Conclusions: Specific parameters routinely assessed intraoperatively during stage 1 sacral neuromodulation for urgency urinary incontinence show limited utility in predicting both acute and long-term outcomes. However, lead position as it relates to the trajectory of the sacral nerve root appears to be important. REFERENCES 1. . Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J Urol.2019; 202(3):558-563. Link, Google Scholar 2. . Onabotulinumtoxin A vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial. JAMA.2016; 316(13):1366-1374. Crossref, Medline, Google Scholar 3. . Two-year outcomes of sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: a randomized trial. Eur Urol.2018; 74(1):66-73. Crossref, Medline, Google Scholar 4. . Predictors of success for first stage neuromodulation: motor versus sensory response. J Urol.2006; 175(6):2178-2181. Link, Google Scholar 5. . Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation?Neurourol Urodyn.2011; 30(8):1489-1492. Crossref, Medline, Google Scholar 6. . Neuromodulation for overactive bladder symptoms in women utilizing either motor or sensory/motor provocation with a minimum nine-year follow-up. Neuromodul Technol Neural Interf.2015; 18(6):517-521. Crossref, Google Scholar 7. . Motor response matters: optimizing lead placement improves sacral neuromodulation outcomes. J Urol.2018; 199(4):1032-1036. Link, Google Scholar 8. . Sacral neuromodulation: determining predictors of success. Urology.2021; 153:124-128. Crossref, Medline, Google Scholar 9. . Is the efficacy of sacral nerve stimulation for faecal incontinence dependent on the number of active electrode poles achieved during permanent lead insertion?Colorectal Dis.2016; 18(11):O414-O419. Crossref, Medline, Google Scholar 10. . Optimal lead positioning in sacral neuromodulation: which factors are related to treatment outcome?Neuromodul Technol Neural Interf.2017; 20(8):830-835. Crossref, Google Scholar 11. . Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during stage 1 sacral neuromodulation. BJU Int.2018; 122(3):472-479. Crossref, Medline, Google Scholar 12. . Association between stimulation parameters and loss of efficacy of selective sacral nerve root stimulation. Neuromodul Technol Neural Interf.2011; 14(3):266-270. Crossref, Google Scholar 13. . Number of active electrodes at time of staged tined lead InterStim implant does not impact clinical outcomes. Neurourol Urodyn.2016; 35(5):625-629. Crossref, Medline, Google Scholar 14. . Patterns of hardware related electrode failures in sacral nerve stimulation devices. J Urol.2013; 190(1):175-179. Link, Google Scholar 15. . The refractory overactive bladder: sacral NEuromodulation vs. BoTulinum toxin Assessment: ROSETTA trial. Contemp Clin Trials.2014; 37(2):272-283. Crossref, Medline, Google Scholar 16. . Reliability of the NINDS myotatic reflex scale. Neurology.1996; 47(4):969-972. Crossref, Medline, Google Scholar 17. . Sacral neuromodulation: troubleshooting needle placement. Int Urogynecol J.2021; 32(9):2549-2551. Crossref, Medline, Google Scholar 18. . Randomized prospective crossover study of InterStim lead wire placement with curved versus straight stylet. Neurourol Urodyn.2014; 33(5):488-492. Crossref, Medline, Google Scholar 19. . Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique. Neurourol Urodyn.2019; 38(6):1595-1601. Crossref, Medline, Google Scholar 20. . The role of pulse width manipulation compared to program changes alone for unsatisfactory sacral neuromodulation therapy: a retrospective matched-cohort analysis. Neurourol Urodyn.2021; 40(1):522-528. Crossref, Medline, Google Scholar 21. Prevalence of abnormal impedance in sacral neuromodulation devices and implications for practice. J Urol.2020; 203:e476-e477. Link, Google Scholar Submitted November 17, 2022; accepted April 14, 2023; published 000. Support: This study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the NIH Office of Research on Women’s Health (Grants U10 HD041261, U10 HD041269, U10 HD069013, U10 HD054214, U10 HD054215, U10 HD041267, U10 HD054241, U10 HD041250, U01 HD041249, U10 HD069025, U10 HD069010, U10 HD069006, U01 HD069031, U10 HD054136, U10 HD041248). Conflict of Interest: Gill, Bradley: Medtronics: food/beverage, consulting; Thomas, Sonia: none; Barden, Lindsey: none; Jelovsek, J. Eric: none; Meyer, Isuzu: none; Chermansky, Christopher: Medtronics: food/beverage, consulting; Komesu, Yuko M.: none; Menefee, Shawn: Medtronics: food/beverage, consulting; Myers, Deborah: none; Smith, Ariana: Medtronics: food/beverage, consulting; Mazloomdoost, Donna: none; Amundsen, Cindy L.: Bluewind: research grant, travel. Ethics Statement: The study received Institutional Review Board (NIH multicenter) approval. This trial is registered at www.ClinicalTrials.gov under Registration No. NCT01502956. © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology22 May 2023Editorial Comment Supplementary Materials Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.Keywordstranscutaneous electric nerve stimulationsacrumimplantable neurostimulatorsoveractiveurinary bladderMetricsAuthor Information Bradley C. Gill Cleveland Clinic, Cleveland, Ohio *Correspondence: Department of Urology, Cleveland Clinic, Mail Stop Q10-1, 9500 Euclid Ave, Cleveland, OH 44195 telephone: 440-461-6430; E-mail Address: [email protected] More articles by this author Sonia Thomas RTI International, Research Triangle Park, North Carolina More articles by this author Lindsey Barden RTI International, Research Triangle Park, North Carolina More articles by this author J. Eric Jelovsek Duke University, Durham, North Carolina More articles by this author Isuzu Meyer University of Alabama at Birmingham, Birmingham, Alabama More articles by this author Christopher Chermansky University of Pittsburgh, Magee-Womens Research Institute, Pittsburgh, Pennsylvania More articles by this author Yuko M. Komesu University of New Mexico, Albuquerque, New Mexico More articles by this author Shawn Menefee University of California San Diego, San Diego, California More articles by this author Deborah Myers Brown University, Providence, Rhode Island More articles by this author Ariana Smith University of Pennsylvania, Philadelphia, Pennsylvania More articles by this author Donna Mazloomdoost Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland More articles by this author Cindy L. Amundsen Duke University, Durham, North Carolina More articles by this author Expand All Submitted November 17, 2022; accepted April 14, 2023; published 000. Support: This study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the NIH Office of Research on Women’s Health (Grants U10 HD041261, U10 HD041269, U10 HD069013, U10 HD054214, U10 HD054215, U10 HD041267, U10 HD054241, U10 HD041250, U01 HD041249, U10 HD069025, U10 HD069010, U10 HD069006, U01 HD069031, U10 HD054136, U10 HD041248). Conflict of Interest: Gill, Bradley: Medtronics: food/beverage, consulting; Thomas, Sonia: none; Barden, Lindsey: none; Jelovsek, J. Eric: none; Meyer, Isuzu: none; Chermansky, Christopher: Medtronics: food/beverage, consulting; Komesu, Yuko M.: none; Menefee, Shawn: Medtronics: food/beverage, consulting; Myers, Deborah: none; Smith, Ariana: Medtronics: food/beverage, consulting; Mazloomdoost, Donna: none; Amundsen, Cindy L.: Bluewind: research grant, travel. Ethics Statement: The study received Institutional Review Board (NIH multicenter) approval. This trial is registered at www.ClinicalTrials.gov under Registration No. NCT01502956. Advertisement PDF downloadLoading ..." @default.
• W4367049649 created "2023-04-27" @default.
• W4367049649 creator A5001783386 @default.
• W4367049649 creator A5014355810 @default.
• W4367049649 creator A5026141955 @default.
• W4367049649 creator A5031643211 @default.
• W4367049649 creator A5031688879 @default.
• W4367049649 creator A5042563940 @default.
• W4367049649 creator A5065864241 @default.
• W4367049649 creator A5070127130 @default.
• W4367049649 creator A5078248175 @default.
• W4367049649 creator A5083804682 @default.
• W4367049649 creator A5085834105 @default.
• W4367049649 creator A5089784611 @default.
• W4367049649 date "2023-08-01" @default.
• W4367049649 modified "2023-10-17" @default.
• W4367049649 title "Intraoperative Predictors of Sacral Neuromodulation Implantation and Treatment Response: Results From the ROSETTA Trial" @default.
• W4367049649 cites W1489433035 @default.
• W4367049649 cites W1582442537 @default.
• W4367049649 cites W1955075128 @default.
• W4367049649 cites W2008662198 @default.
• W4367049649 cites W2042078649 @default.
• W4367049649 cites W2063685281 @default.
• W4367049649 cites W2071052332 @default.
• W4367049649 cites W2125383851 @default.
• W4367049649 cites W2163567692 @default.
• W4367049649 cites W2167980908 @default.
• W4367049649 cites W2520636656 @default.
• W4367049649 cites W2528575688 @default.
• W4367049649 cites W2753377364 @default.
• W4367049649 cites W2771008069 @default.
• W4367049649 cites W2787906061 @default.
• W4367049649 cites W2797435892 @default.
• W4367049649 cites W2942909770 @default.
• W4367049649 cites W3039954994 @default.
• W4367049649 cites W3111715181 @default.
• W4367049649 cites W3120170579 @default.
• W4367049649 cites W4213351464 @default.
• W4367049649 doi "https://doi.org/10.1097/ju.0000000000003498" @default.
• W4367049649 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37126070" @default.
• W4367049649 hasPublicationYear "2023" @default.
• W4367049649 type Work @default.
• W4367049649 citedByCount "0" @default.
• W4367049649 crossrefType "journal-article" @default.
• W4367049649 hasAuthorship W4367049649A5001783386 @default.
• W4367049649 hasAuthorship W4367049649A5014355810 @default.
• W4367049649 hasAuthorship W4367049649A5026141955 @default.
• W4367049649 hasAuthorship W4367049649A5031643211 @default.
• W4367049649 hasAuthorship W4367049649A5031688879 @default.
• W4367049649 hasAuthorship W4367049649A5042563940 @default.
• W4367049649 hasAuthorship W4367049649A5065864241 @default.
• W4367049649 hasAuthorship W4367049649A5070127130 @default.
• W4367049649 hasAuthorship W4367049649A5078248175 @default.
• W4367049649 hasAuthorship W4367049649A5083804682 @default.
• W4367049649 hasAuthorship W4367049649A5085834105 @default.
• W4367049649 hasAuthorship W4367049649A5089784611 @default.
• W4367049649 hasConcept C126322002 @default.
• W4367049649 hasConcept C141071460 @default.
• W4367049649 hasConcept C24998067 @default.
• W4367049649 hasConcept C2780375056 @default.
• W4367049649 hasConcept C3017551082 @default.
• W4367049649 hasConcept C71924100 @default.
• W4367049649 hasConceptScore W4367049649C126322002 @default.
• W4367049649 hasConceptScore W4367049649C141071460 @default.
• W4367049649 hasConceptScore W4367049649C24998067 @default.
• W4367049649 hasConceptScore W4367049649C2780375056 @default.
• W4367049649 hasConceptScore W4367049649C3017551082 @default.
• W4367049649 hasConceptScore W4367049649C71924100 @default.
• W4367049649 hasIssue "2" @default.
• W4367049649 hasLocation W43670496491 @default.
• W4367049649 hasLocation W43670496492 @default.
• W4367049649 hasOpenAccess W4367049649 @default.
• W4367049649 hasPrimaryLocation W43670496491 @default.
• W4367049649 hasRelatedWork W2003938723 @default.
• W4367049649 hasRelatedWork W2047967234 @default.
• W4367049649 hasRelatedWork W2118496982 @default.
• W4367049649 hasRelatedWork W2130554639 @default.
• W4367049649 hasRelatedWork W2364998975 @default.
• W4367049649 hasRelatedWork W2439875401 @default.
• W4367049649 hasRelatedWork W2761766381 @default.
• W4367049649 hasRelatedWork W2774914139 @default.
• W4367049649 hasRelatedWork W4238867864 @default.
• W4367049649 hasRelatedWork W2525756941 @default.
• W4367049649 hasVolume "210" @default.
• W4367049649 isParatext "false" @default.
• W4367049649 isRetracted "false" @default.
• W4367049649 workType "article" @default.